Whereas it may appear that Ac-PSMA has had a slower development trajectory compared to Lu-PSMA radioligand therapy, Dr. Eiber ...

(UroToday.com) The 2026 PSMA & Beyond conference featured a clinical trial updates session and presentation by Dr. Michael Morris discussing DORA and PEACE-3 and the evolving role of radium-223. Dr.

The study met its primary endpoint of radiographic progression free survival, which was significantly prolonged with the ...

Dr. Bodei notes that there are differences between PET versus SPECT. PET has high sensitivity and is a biological signal, whereas SPECT is therapy linked and used in dosimetry. SPECT also informs ...

The 2026 PSMA and Beyond conference featured an approaches to combination therapies session and presentation by Dr. Lawrence ...

Dr. Watabe notes that in his home of Osaka, Japan, there is a new cyclotron (MP-30X, Sumitomo) dedicated to the production of 211 At, which will be installed at the University of Osaka in May 2026.

At the 2026 PSMA and Beyond annual meeting, Robert Reiter discusses the problems with our PSMA PET reports. Dr. Reiter ...

The 2026 SESAUA annual meeting featured a bladder cancer session and a presentation by Dr. William Huang discussing the ...

Urethral Bulkamid is a U.S. Food and Drug Administration-approved nonsurgical treatment for stress urinary incontinence and stress-predominant mixed urinary incontinence due to intrinsic sphincter ...